Learn More
Medchemexpress LLC Immh-010 maleate | 2541982-47-0 | 99.8% | 756.04 | 5 MG

Supplier: Medchemexpress LLC HY1678405MG
IMMH-010 maleate is a prodrug that acts as a novel PD-L1 inhibitor, showing potential antitumor activity. It is being investigated for the treatment of neurological disorders and advanced malignant solid tumors. Upon oral administration, it quickly converts into its active form, YPD-29B. This compound is significant for advancing research in the field of PD-L1 inhibitors and related therapeutic applications.
- Acts as a novel PD-L1 inhibitor
- Shows potential antitumor activity
- Investigated for neurological disorders and advanced malignant solid tumors
- Converts into active form, YPD-29B, upon oral administration
- Advances research in PD-L1 inhibitors and related therapeutic applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.